SRDX: Surmodics Company Sales Revenue

High confidence in the biocompatible coatings of Surmodics, Inc. (SRDX) has established a brand foundation, as evidenced by the company's upward sales trajectory. Optimization via contract manufacturing and cloud logistics has strengthened operational flexibility, while the 0.12 indicator reflects the current state of the metric. This has ensured a steady stream of royalty payments and a cash surplus with minimal costs.

Revenue and Sales Volume: Surmodics (SRDX) for 07/04/2022 - 11/29/2025

Comprehensive metric breakdowns and analytics for Surmodics (SRDX)

- stock value and consensus price forecast:

Stock Quotes Surmodics Inc.|SRDX - Consensus Target

- market capitalization information:

Market Value Surmodics, Inc.|SRDX - Total Company Value

- balance sheet net asset value indicators:

Accounting Value per Share Surmodics|SRDX - Book Capitalization|Market-to-Book Ratio surmodics.com|SRDX - Company Total Assets

- company liabilities and liquidity data:

- company profitability and valuation multiples indicators:

SRDX - Net Income|Expected Net Income Surmodics, Inc.|SRDX - P/E Multiple|Projected Price to Earnings Ratio surmodics.com|SRDX - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Multiple Surmodics, Inc.|SRDX - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Surmodics|SRDX - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months surmodics.com|SRDX - Earnings per share growth in current year|Net earnings per share change forecast for next year Surmodics, Inc.

- company sales and revenue statistics:

SRDX - Company Revenue|Company Future Sales Volume Surmodics Inc.|SRDX - P/S Multiple|Market Cap to Future Revenue Ratio Surmodics, Inc.

Summary company analysis:SRDX Surmodics Inc.

Surmodics, Inc. sales reflect the actual cash inflow from the sale of core products, capturing the consistency of operational flows. This metric is critical for investors to assess the business's ability to service debt and avoid liquidity gaps. Analyzing the company's sales time series reveals high revenue stability. For Surmodics, Inc. (SRDX), such resilience is ensured by long-term licensing agreements. Patent protection for medical coatings creates inertial demand, maintaining capital generation at maximum levels.

Key competitors